Korsen M, Pfeuffer S, Rolfes L, Meuth SG, et al. Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod-potentials and risks of subsequent highly active agents. J Neurol 2022 Jan 9. pii: 10.1007/s00415-021-10956.
PMID: 34999925